Tavy Deming is a partner at Kenney & McCafferty. Since joining the firm in 2005, Ms. Deming exclusively represents whistleblowers in filing claims under the Federal and state False Claims Acts, the IRS Whistleblower Program and the SEC Whistleblower Program.
Ms. Deming’s record on behalf of whistleblowers speaks for itself. She represented clients in the three largest False Claims Act settlements in U.S. history, including the historic 2012 $3 billion GlaxoSmithKline global settlement that surpassed the then-record 2009 $2.3 billion Pfizer global settlement. Most recently, Ms. Deming represented the former Chief Compliance Officer of medical device titan Olympus resulting in yet another landmark settlement. The $646 million settlement, announced in March 2016, stands as the largest settlement of Anti-Kickback Statute violations in U.S. history and the largest settlement amount ever paid by a medical device company.
Consistently recognized by Philadelphia Magazine as one of Philadelphia’s Super Lawyers, Ms. Deming’s extensive repertoire also includes litigation of state and Federal False Claims Act cases. Ms. Deming is presently litigating companion whistleblower lawsuits pending in Texas state court and in the Eastern District of New York. Fortifying Ms. Deming’s experience in whistleblower litigation is a seven-year tenure engaged in complex commercial litigation prior to joining the firm.
Ms. Deming earned her law degree from Villanova University in 1998 and her college degree from James Madison University. Ever the sports enthusiast, Ms. Deming earned an athletic scholarship to play for the James Madison University Women’s Golf Team. In 1993, Ms. Deming graduated magna cum laude having also earned Academic All-American Honors.